No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results8 funds hold a position and insiders have been net selling.
Buys/Adds (3)
Qube Research
$243.5M
added
Citadel
$149.3M
added
Two Sigma
$137.6M
added
Sells (1)
Tooker Adin M
$1.2M
sold
Top-trader positions in HIG could not be loaded.
Hyperliquid positioning - not every stock is covered
Last report
Jul 23, 2026
Period ending
Jun 30, 2026
Earnings per share
$3.14 expected
Estimates as of Oct 24, 2026
EPS expected
$2.90 to $4.61
Revenue expected
3 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 23, 2026 | $3.42 / $3.14Yahoo Finance | +8.93% beat | $7.26B No estimateSEC filing | Unavailable |
| Mar 31, 2026 | Apr 23, 2026 | $3.09 / $3.39Yahoo Finance | -8.83% miss | $7.23B No estimate | Unavailable |
| Dec 31, 2025 | Jan 29, 2026 | $4.06 / $3.22Yahoo Finance | +26.23% beat | $7.31B No estimate | Unavailable |
| Sep 30, 2025 | Oct 27, 2025 | $3.78 / $3.21Yahoo Finance | +17.59% beat | $7.23B No estimate | Unavailable |
| Jun 30, 2025 | Jul 28, 2025 | $3.41 / $2.83Alpha Vantage | +20.49% beat | $6.72B No estimateSEC filing | Unavailable |
| Mar 31, 2025 | Apr 24, 2025 | $2.20 / $2.15Alpha Vantage | +2.33% beat | $6.81B No estimate | Unavailable |
| Dec 31, 2024 | Jan 30, 2025 | $2.94 / $2.64Alpha Vantage | +11.36% beat | $6.80B No estimate | Unavailable |
| Sep 30, 2024 | Oct 24, 2024 | $2.53 / $2.53Alpha Vantage | +0.00% in line | $6.71B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $7.23B | $7.31B | $7.23B | $7.26B |
| Cost of what it sold | $3.79B | $3.73B | $4.00B | $4.75B |
| Gross profit | $3.44B | $3.58B | $3.23B | $2.51B |
| What it spent | ||||
| Sales and admin | — | — | — | $1.22B |
| Other operating costs | $2.12B | $2.17B | $2.17B | $669.0M |
| Total operating expenses | $2.12B | $2.17B | $2.17B | $1.88B |
| What was left | ||||
| Operating profit | $1.32B | $1.41B | $1.06B | $629.0M |
| Interest on debt | $50.0M | $49.0M | $50.0M | $50.0M |
| Profit before tax | $1.32B | $1.41B | $1.06B | $1.23B |
| Tax | $238.0M | $282.0M | $201.0M | $251.0M |
| Net profit | $1.08B | $1.13B | $856.0M | $1.30B |
| EBITDA | $1.44B | $1.60B | $1.22B | $646.0M |
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace